DURECT Corporation, a biopharmaceutical company, researches and develops
medicines based on its epigenetic regulator and pharmaceutical
programs. The company offers ALZET product line that consists of osmotic
pumps and accessories used for experimental research in mice, rats, and
other laboratory animals; and a range of biodegradable polymers for
pharmaceutical and medical device clients for use as raw materials in
their products under the LACTEL brand. Its product pipeline consists of
multiple investigational drug candidates in development, such as
DUR-928, an endogenous, orally bioavailable small molecule that is in
Phase I and II development stage to play a regulatory role in lipid
homeostasis, inflammation, and cell survival.
37 year old trader uses this “unconventional” strategy to turn $10K into $2.4 million in only 18 months. Another trader turned $5K into $15 million and still another turned $30K into $80 million. Click here to discover their millionaire maker strategy. [ad]
There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.